Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel three-step synthesis route for 5-trifluoromethyl uracil offers high yield and low pollution. Ideal for antiviral drug supply chain optimization and cost reduction.
Novel one-pot method for Imatinib intermediate reduces toxicity and improves yield for pharmaceutical manufacturing supply chains.
Patent CN115872928A reveals a breakthrough one-pot method for pyridine choline ester, eliminating costly silver salts and significantly reducing manufacturing complexity.
Novel preparation method for MER/FLT3 dual-inhibitor intermediate offering high yield and cost-effective pharmaceutical manufacturing solutions for global supply chains and procurement.
Patent CN102381990A details a cost-effective Ruthenium-catalyzed asymmetric hydrogenation route for N-benzyl phenylephrine intermediates, offering superior purity and supply chain reliability.
Patent CN102070468B reveals a high-yield route for Ractopamine. Reduced waste, >93% purity. Ideal for reliable pharmaceutical intermediate suppliers seeking cost efficiency.
Advanced patent CN104628622A offers high-yield Saxagliptin intermediate synthesis. Ensures supply chain stability and cost efficiency for global pharma.
Patent CN106167449B reveals cyclic Fries rearrangement improving yield and purity. Enables cost reduction in fine chemical manufacturing and reliable supply chain.
Novel chemical route for D-norvaline from n-pentanoic acid offers cost reduction in API manufacturing and high purity for chiral drug synthesis.
Patent CN114956924B reveals a novel Pd-catalyzed method for polyfluorinated biarenes. Discover cost-effective supply chain solutions and high-purity manufacturing capabilities.
Patent CN102020546B details a novel synthesis for bis-(2,3,6-tribromo-4,5-dimethoxy-phenyl)-methanone, offering a scalable route for high-purity pharmaceutical intermediates.
Patent CN111943950A details a safer, one-pot synthesis for Relebactam intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN103665078B reveals a safer synthesis route for steroidal esters. This method avoids hazardous reagents, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN1241914C details an efficient method for 7-quinolinyl-3,5-dihydroxyhept-6-enoate, offering superior purity and scalable production for HMG-CoA inhibitor manufacturing.
Patent CN101602751A reveals a cost-effective, aqueous-based synthesis for Cinepazide Maleate intermediates, offering significant supply chain and safety advantages.
Discover the novel preparation method for Sulcardine free base via CN112110879A. Enhanced yield, reduced impurities, and scalable manufacturing for reliable API intermediate supply.
Novel short-route synthesis for Dabigatran Etexilate. High yield, scalable process reducing manufacturing costs for anticoagulant drug intermediates.
Patent CN103497202A details a safer reduction method for dorzolamide intermediates, eliminating toxic boranes and improving yield for reliable supply.
Novel synthesis method for Buparvaquone intermediate ensures high purity and scalable production for global veterinary pharmaceutical supply chains reducing manufacturing complexity.
Patent CN113880720A reveals a novel FeCl3-catalyzed reduction for Mirabegron intermediates, offering significant cost reduction and enhanced safety for API manufacturing supply chains.